Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS One ; 10(12): e0144033, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26641473

RESUMEN

Chagas' disease is an infection that is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwide. Because of severe side effects and variable efficacy, the current treatments for Chagas' disease are unsatisfactory, making the search for new chemotherapeutic agents essential. Previous studies have reported various biological activities of naphthoquinones, such as the trypanocidal and antitumor activity of vitamin K3. The combination of this vitamin with vitamin C exerted better effects against various cancer cells than when used alone. These effects have been attributed to an increase in reactive oxygen species generation. In the present study, we evaluated the activity of vitamin K3 and vitamin C, alone and in combination, against T. cruzi. The vitamin K3 + vitamin C combination exerted synergistic effects against three forms of T. cruzi, leading to morphological, ultrastructural, and functional changes by producing reactive species, decreasing reduced thiol groups, altering the cell cycle, causing lipid peroxidation, and forming autophagic vacuoles. Our hypothesis is that the vitamin K3 + vitamin C combination induces oxidative imbalance in T. cruzi, probably started by a redox cycling process that leads to parasite cell death.


Asunto(s)
Ácido Ascórbico/farmacología , Trypanosoma cruzi/metabolismo , Vitamina K 3/farmacología , Animales , Ácido Ascórbico/agonistas , Línea Celular , Enfermedad de Chagas/tratamiento farmacológico , Enfermedad de Chagas/metabolismo , Sinergismo Farmacológico , Macaca mulatta , Oxidación-Reducción , Especies Reactivas de Oxígeno/metabolismo , Vitamina K 3/agonistas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA